Insider · CIK 0002000226
Jewell Christopher M
officer
Files at RNAC (Cartesian Therapeutics, Inc.). First filing Nov 18, 2024, latest Nov 18, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $875k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 58Moderate | sell 3 | RNAC Cartesian Therapeutics, Inc. | $875k | 52,115 | -84% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | RNAC Cartesian Therapeutics, Inc. | MOption exercise Common Stock | +14,000 | $3.23 | $45k | 39,940 | Nov 21, 2024 |
| Nov 20, 2024 | RNAC Cartesian Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -14,000 | - | - | 76,432 | Nov 21, 2024 |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | MOption exercise Common Stock | +36,050 | $3.23 | $116k | 61,990 | Nov 18, 2024 |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | SOpen-market sale Common Stock | -18,550 | $16.34 | $303k | 43,440 | Nov 18, 2024 |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | SOpen-market sale Common Stock | -17,500 | $17.02 | $298k | 25,940 | Nov 18, 2024 |
| Nov 15, 2024 | RNAC Cartesian Therapeutics, Inc. | MOption exercise Common Stock | +16,065 | $3.23 | $52k | 42,005 | Nov 18, 2024 |
| Nov 15, 2024 | RNAC Cartesian Therapeutics, Inc. | SOpen-market sale Common Stock | -16,065 | $17.06 | $274k | 25,940 | Nov 18, 2024 |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -36,050 | - | - | 106,497 | Nov 18, 2024 |
| Nov 15, 2024 | RNAC Cartesian Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -16,065 | - | - | 90,432 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.